Medical device manufacturer C.R. Bard will face the first of hundreds of transvaginal mesh lawsuits in a federal court beginning in 2013. The lawsuit alleges that Bard’s Avaulta transvaginal surgical mesh device failed and caused organ damage.
Judge Joseph Goodwin ordered the first of nearly 600 federal cases over the mesh to begin in district court early next year. Goodwin stated that the rest of the trials will be determined after the plaintiffs and Bard exchange pretrial information. The manufacturer also faces several lawsuits over transvaginal mesh at the state level.
More than 75,000 women receive a transvaginal mesh device every year to treat pelvic organ prolapse, stress urinary incontinence or similar issues. Many of the devices—some of which were passed without significant clinical trials—have been found to fail at higher rates than expected, leading to complications, including severe discomfort, limited mobility and organ damage.